The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patientsCheng He, Chen Liu, Jiang Long et al.|Pancreatology|2016Cited by 65
Epithelial–mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?Jia-Hao Jiang, Xianjun Yu, Chen Liu et al.|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2014Cited by 42